{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:13:16Z","timestamp":1789985596123,"version":"4.0.1"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,6]]},"DOI":"10.18632\/oncotarget.13250","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T22:54:00Z","timestamp":1478732040000},"page":"81870-81879","source":"Crossref","is-referenced-by-count":42,"title":["Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies"],"prefix":"10.18632","volume":"7","author":[{"given":"Ran","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550000, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ju","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, Guizhou, China"},{"name":"Department of Respiratory Medicine, The Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang 550014, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-li","family":"Zhu","sequence":"additional","affiliation":[{"name":"Blood Transfusion Department, The Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang 550014, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[{"name":"Prenatal Diagnostic Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ke","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550000, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-hui","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550000, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-zhen","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550000, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550000, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-juan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550000, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550000, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zun-feng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, Guiyang 550000, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, The Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang 550014, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-zi","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, The Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang 550014, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-jing","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, The Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang 550014, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Clinical practice","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"Gout. N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"3","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2014.839","article-title":"Recurrence and mortality following severe cutaneous adverse reactions","volume":"311","author":"Juurlink","year":"2014","journal-title":"JAMA"},{"key":"4","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Stern","year":"1994","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.gene.2013.03.005","article-title":"The DEER database: a bridge connecting drugs, environmental effects, and regulations","volume":"520","author":"Huang","year":"2013","journal-title":"Gene"},{"key":"6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/gim.2014.195","article-title":"An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing","volume":"17","author":"Kang","year":"2015","journal-title":"Genet Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/tpj.2011.41","article-title":"A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"13","author":"Ikeda","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.13688","article-title":"HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study","volume":"173","author":"Zhou","year":"2015","journal-title":"Br J Dermatol"},{"key":"10","first-page":"383","article-title":"Detection of HLA-B*58:01 with TaqMan assay and its association with allopurinol-induced sCADR","volume":"53","author":"Guan","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2217\/pgs.11.131","article-title":"Allopurinol pharmacogenetics: assessment of potential clinical usefulness","volume":"12","author":"Pacanowski","year":"2011","journal-title":"Pharmacogenomics"},{"key":"12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jid.2016.02.808","article-title":"Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions","volume":"136","author":"Wu","year":"2016","journal-title":"J Invest Dermatol"},{"key":"13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3349\/ymj.2016.57.1.118","article-title":"HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS\/TEN According to Culprit Drugs","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Med J"},{"key":"14","first-page":"143","article-title":"HLA-B*5801 carrying station and the correlation of allergic reactions caused by allopurinol","volume":"45","author":"Zhang","year":"2015","journal-title":"J Wenzhou Medical University"},{"key":"15","first-page":"700","article-title":"Research on detection methods for HLA-B*5801: a biomarker for allopurinol induced serious cutaneous adverse drug reactions","volume":"32","author":"Chen","year":"2015","journal-title":"Chin J Mod Appl Pharm"},{"key":"16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjd.12389","article-title":"HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Portuguese population","volume":"169","author":"Martinho","year":"2013","journal-title":"Br J Dermatol"},{"key":"17","first-page":"258","article-title":"Correlation between HLA-B*5801 allele and allopurinol-induced severe cutaneous adverse reaction in Han ethnic group patients in Jiangsu province","volume":"15","author":"Miao","year":"2013","journal-title":"Adverse Drug Reactions J"},{"key":"18","first-page":"379","article-title":"Detection of the HLA-B *5801 allele in Han Chinese with allopurinol-induced severe drug eruption","volume":"20","author":"Yang","year":"2013","journal-title":"J Diagn Ther Dermota-Venereol"},{"key":"19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2013.04.013","article-title":"HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population","volume":"71","author":"Morita","year":"2013","journal-title":"J Dermatol Sci"},{"key":"20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2133.2012.10894.x","article-title":"Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong","volume":"167","author":"Tomlinson","year":"2012","journal-title":"Br J Dermatol"},{"key":"21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/pgs.12.89","article-title":"HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese","volume":"13","author":"Ma","year":"2012","journal-title":"Pharmacogenomics"},{"key":"22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","article-title":"Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans","volume":"21","author":"Lee","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"23","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1093\/ndt\/gfr060","article-title":"HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency","volume":"26","author":"Kang","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1744-313X.2011.01011.x","article-title":"A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"38","author":"Cutrupi","year":"2011","journal-title":"Int J Immunogenet"},{"key":"25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"26","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Ikeda","year":"2008","journal-title":"Pharmacogenomics"},{"key":"27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Hovnanian","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"28","first-page":"186","article-title":"HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand","volume":"7","author":"Rerkpattanapipat","year":"2016","journal-title":"Front Pharmacol"},{"key":"29","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Shapiro","year":"1995","journal-title":"N Engl J Med"},{"key":"30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Roujeau","year":"2007","journal-title":"Br J Dermatol"},{"key":"31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tig.2004.06.014","article-title":"Meta-analysis of genetic association studies","volume":"20","author":"Flint","year":"2004","journal-title":"Trends Genet"},{"key":"32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/clpt.2012.209","article-title":"Clinical pharmacogenetics implementation consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing","volume":"93","author":"Lee","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"33","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"key":"34","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance","volume":"56","author":"Bossuyt","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0196-0644(98)70352-X","article-title":"Clinical utility of likelihood ratios","volume":"31","author":"Gallagher","year":"1998","journal-title":"Ann Emergency Med"},{"key":"36","first-page":"h4848","article-title":"Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study","volume":"351","author":"Lai","year":"2015","journal-title":"BMJ"},{"key":"37","doi-asserted-by":"crossref","first-page":"e94294","DOI":"10.1371\/journal.pone.0094294","article-title":"Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS\/TEN in Thai population","volume":"9","author":"Chaiyakunapruk","year":"2014","journal-title":"PloS One"},{"key":"38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/acr.22409","article-title":"Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea","volume":"67","author":"Lee","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"39","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2217\/pgs.15.125","article-title":"Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore","volume":"16","author":"Sung","year":"2015","journal-title":"Pharmacogenomics"},{"key":"40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Roujeau","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"41","unstructured":"Lin, Chen, Hung. The pathogenic role of HLA-B*5801 in allopurinol-induced severe cutaneous adverse reactions. Presented at: Drug Hypersensitivity Meeting - DHM5. Munich. 2012. Programme and Abstract Book. 2012; p. 125."},{"key":"42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"43","first-page":"139","article-title":"Report of the Japanese Central Bone Marrow Data Center","author":"Juji","year":"1996","journal-title":"Clin Transpl"},{"key":"44","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Laird","year":"1986","journal-title":"Control Clin Trials"},{"key":"46","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-2-9","article-title":"Conducting systematic reviews of diagnostic studies: didactic guidelines","volume":"2","author":"Bezemer","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"48","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Gatsonis","year":"2001","journal-title":"Stat Med"},{"key":"49","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Mazumdar","year":"1994","journal-title":"Biometrics"},{"key":"50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Minder","year":"1997","journal-title":"BMJ"},{"key":"51","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Irwig","year":"2005","journal-title":"J Clin Epidemiol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:59:16Z","timestamp":1596722356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":51,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2016,12,6]]}},"alternative-id":["13250","27835909"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13250","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}